Related references
Note: Only part of the references are listed.A randomized clinical trial of granulocyte macrophage colony stimulating factor mouthwash for oral mucositis in head and neck cancer
Marylin J. Dodd et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2022)
The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent
Victor D. Cuevas et al.
JOURNAL OF INNATE IMMUNITY (2022)
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
Alexander C. Huang et al.
NATURE IMMUNOLOGY (2022)
IL-3 signalling in the tumour microenvironment shapes the immune response via tumour endothelial cell-derived extracellular vesicles
Tatiana Lopatina et al.
PHARMACOLOGICAL RESEARCH (2022)
Classification and Staging of Melanoma in the Head and Neck
Anthony M. Bunnell et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2022)
G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors
Kai He et al.
FEBS OPEN BIO (2022)
Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity
Rosmely Hernandez et al.
FRONTIERS IN ONCOLOGY (2022)
Blocking the Notch signal transduction pathway promotes tumor growth in breast cancer by promoting the expression of suppressible inflammatory factors
Shuguang Ren et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
Emma H. A. Stahlie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
G-CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment
Ebtehag Maneta et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)
Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer
Farnaz Hajizadeh et al.
LIFE SCIENCES (2021)
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
Joel Guigay et al.
LANCET ONCOLOGY (2021)
Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation
Yu-Chih Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Hani Babiker et al.
ONCOLOGIST (2021)
New insights into M1/M2 macrophages: key modulators in cancer progression
Jiuyang Liu et al.
CANCER CELL INTERNATIONAL (2021)
G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation
Ioannis Karagiannidis et al.
CYTOKINE (2021)
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Hillard M. Lazarus et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunomodulatory effects of G-CSF in cancer: Therapeutic implications
Kellie A. Mouchemore et al.
SEMINARS IN IMMUNOLOGY (2021)
Clinical evaluation of colony-stimulating factor 1 receptor inhibitors
Peter Ordentlich
SEMINARS IN IMMUNOLOGY (2021)
Colony Stimulating Factor-1 and its Receptor in Gastrointestinal Malignant Tumors
Hong-wu Li et al.
JOURNAL OF CANCER (2021)
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
Richard M. Logan et al.
SUPPORTIVE CARE IN CANCER (2020)
A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors
Yong Fang et al.
CLINICAL CANCER RESEARCH (2020)
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
Lea Paolini et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases
Lin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
Brooke Benner et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2020)
Head and neck sarcomas in adulthood: current trends and evolving management concepts
N. Kalavrezos et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2020)
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
Naoko Komura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Targeted Therapy in Melanoma and Mechanisms of Resistance
Anna M. Czarnecka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prognostic significance of multi-positive invasive histopathology in oral cancer
John Adeoye et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2020)
Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor
Shanada Monestime et al.
DRUGS IN R&D (2020)
G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
Ioannis Karagiannidis et al.
FRONTIERS IN IMMUNOLOGY (2020)
G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth
Ioannis Karagiannidis et al.
CANCERS (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
The transition of M-CSF-derived human macrophages to a growth-promoting phenotype
Kajal Hamidzadeh et al.
BLOOD ADVANCES (2020)
The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy
Zhe Ge et al.
FRONTIERS IN ONCOLOGY (2020)
A randomized phase II study of cabiralizumab (cabira) plus nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC).
Andrea Wang-Gillam et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation
Michael Dougan et al.
IMMUNITY (2019)
Evaluation of pro- and anti-tumor effects induced by three colony-stimulating factors, G-CSF, GM-CSF and M-CSF, in bladder cancer cells: Is G-CSF a friend of bladder cancer cells?
Shunta Hori et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma
Ghazi Alsbeih et al.
CANCERS (2019)
M-CSF Receptor Antagonists Inhibit the Initiation and Progression of Hepatocellular Carcinoma in Mice
Yoshihiro Akazawa et al.
ANTICANCER RESEARCH (2019)
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data
Adriana Blakaj et al.
ORAL ONCOLOGY (2019)
Prognostic Role of Blood NETosis in the Progression of Head and Neck Cancer
Anna Sophie Decker et al.
CELLS (2019)
Signal Integration and Transcriptional Regulation of the Inflammatory Response Mediated by the GM-/M-CSF Signaling Axis in Human Monocytes
Ramon M. Rodriguez et al.
CELL REPORTS (2019)
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard et al.
ORAL ONCOLOGY (2019)
Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy
Kuirong Mao et al.
BIOMATERIALS SCIENCE (2019)
Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis
Emily A. Merkel et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination
Chen Varol et al.
FEBS JOURNAL (2018)
Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages
Stefano Bonelli et al.
FEBS JOURNAL (2018)
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Praveen K. Bommareddy et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Recent progress in GM-CSF-based cancer immunotherapy
Wan-Lun Yan et al.
IMMUNOTHERAPY (2017)
Neutrophils as active regulators of the immune system in the tumor microenvironment
Merav E. Shaul et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Predictors of survival in head and neck mucosal melanoma
Matthew Q. Schmidt et al.
ORAL ONCOLOGY (2017)
CSF-1R Inhibitor Development: Current Clinical Status
Florent Peyraud et al.
CURRENT ONCOLOGY REPORTS (2017)
Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
Aibin Zhang et al.
CANCER MEDICINE (2017)
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Omid Hamid et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Mucosal melanoma of the head and neck
Paolo Antonio Ascierto et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Chemotherapy for recurrent/metastatic head and neck cancers
Andy Karabajakian et al.
ANTI-CANCER DRUGS (2017)
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
Eva Van Overmeire et al.
CANCER RESEARCH (2016)
Update on primary head and neck mucosal melanoma
Fernando Lopez et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Granulocyte colony-stimulating factor impairs CD8+ T cell functionality by interfering with central activation elements
C. E. Bunse et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H. I. Andtbacka et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Burkhard Becher et al.
IMMUNITY (2016)
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Kelly L. Singel et al.
IMMUNOLOGICAL REVIEWS (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tumor- associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma
Yong Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Bioprocess development for extracellular production of recombinant human interleukin-3 (hIL-3) in Pichia pastoris
Vikas Kumar Dagar et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2016)
Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage
Irina Ushach et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer
Yan Yan et al.
ONCOTARGETS AND THERAPY (2016)
Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1
Huayang Wang et al.
ONCOIMMUNOLOGY (2016)
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
In-Sun Hong
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
J. Guigay et al.
ANNALS OF ONCOLOGY (2015)
18TiP * Phase 1/2a study of double immune suppression blockade by combining a CSF1R inhibitor (pexidartinib/PLX3397) with an anti PD-1 antibody (pembrolizumab) to treat advanced melanoma and other solid tumors
S. Hu-Lieskovan et al.
ANNALS OF ONCOLOGY (2015)
Carbonic Anhydrase IX Promotes Myeloid-Derived Suppressor Cell Mobilization and Establishment of a Metastatic Niche by Stimulating G-CSF Production
Shawn C. Chafe et al.
CANCER RESEARCH (2015)
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation
Saurabh Agarwal et al.
CANCER RESEARCH (2015)
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H. Lawson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Palash Bhattacharya et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor
Y-H Cui et al.
ONCOGENE (2015)
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Li Wang et al.
SUPPORTIVE CARE IN CANCER (2015)
M-CSF from Cancer Cells Induces Fatty Acid Synthase and PPARβ/δ Activation in Tumor Myeloid Cells, Leading to Tumor Progression
Jonghanne Park et al.
CELL REPORTS (2015)
A phase I dose escalation trial of MAGE-A3-and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
Dan P. Zandberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Adjuvant GM-CSF Improves Survival in High-risk Stage IIIC Melanoma A Single-center Study
Travis E. Grotz et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration
K. T. Morris et al.
BRITISH JOURNAL OF CANCER (2014)
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent
Linda J. Bendall et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas
Tobias Ettl et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2014)
Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011
Boudewijn J. M. Braakhuis et al.
ORAL ONCOLOGY (2014)
Head and Neck Sarcomas: Analysis of the SEER Database
Kevin A. Peng et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2014)
Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study
B. Linot et al.
SUPPORTIVE CARE IN CANCER (2014)
Macrophage colony-stimulating factor and cancer: a review
S. Chockalingam et al.
TUMOR BIOLOGY (2014)
A role for G-CSF and GM-CSF in nonmyeloid cancers
Alexander M. Aliper et al.
CANCER MEDICINE (2014)
Functional relationship between tumor-associated macropnages and macropnage colony-stimulating factor as contributors to cancer progression
Damya Laoui et al.
FRONTIERS IN IMMUNOLOGY (2014)
Myeloid colony-stimulating factors as regulators of macrophage polarization
Thomas A. Hamilton et al.
FRONTIERS IN IMMUNOLOGY (2014)
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
Niccolo Bartalucci et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Jonathan Cools-Lartigue et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Inhibitory Effect of Natural Anti-Inflammatory Compounds on Cytokines Released by Chronic Venous Disease Patient-Derived Endothelial Cells
Veronica Tisato et al.
MEDIATORS OF INFLAMMATION (2013)
Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer
Yukinori Takenaka et al.
SUPPORTIVE CARE IN CANCER (2013)
GM-CSF enhances tumor invasion by elevated MMP-2,-9, and-26 expression
Claudia M. Gutschalk et al.
CANCER MEDICINE (2013)
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
Lianne van de Laar et al.
BLOOD (2012)
The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
Sophie E. Broughton et al.
IMMUNOLOGICAL REVIEWS (2012)
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
Melanie Demers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials
Mario Turriziani et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Predictors of Survival in Mucosal Melanoma of the Head and Neck
Daniel Jethanamest et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF
Elvis Atanga et al.
BONE (2011)
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2011)
Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors
Marco Danova et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Tumor Location Predicts Survival in Cutaneous Head and Neck Melanoma
Warren H. Tseng et al.
JOURNAL OF SURGICAL RESEARCH (2011)
IL-3 is a novel target to interfere with tumor vasculature
P. Dentelli et al.
ONCOGENE (2011)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors
Konstantin H. Dragnev et al.
CHEMOTHERAPY (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous Done marrow af
Atif M. Hussein et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Tolerogenic dendritic cells and myeloid-derived suppressor cells: Potential for regulation and therapy of liver auto- and alloimmunity
Sudha Natarajan et al.
IMMUNOBIOLOGY (2010)
HPV-associated head and neck cancer: a virus-related cancer epidemic
Shanthi Marur et al.
LANCET ONCOLOGY (2010)
The colony-stimulating factors and cancer
Donald Metcalf
NATURE REVIEWS CANCER (2010)
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization
Matthew J. Christopher et al.
BLOOD (2009)
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2009)
Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more
Clifford Liongue et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Survival following primary surgery for oral cancer
Simon N. Rogers et al.
ORAL ONCOLOGY (2009)
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
Farbod Shojaei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer
Tanguy Y. Seiwert et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Out of breath: GM-CSFRα mutations disrupt surfactant homeostasis
Luigi D. Notarangelo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma
Miguel-Angel Perales et al.
MOLECULAR THERAPY (2008)
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina et al.
PLOS ONE (2008)
M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo
Jennifer M. Curry et al.
PLOS ONE (2008)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of radiation therapy oncology group protocol 9911
Corey J. Langer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Human monocytes kill M-CSF-expressing glioma cells by BK channel activation
Neil T Hoa et al.
LABORATORY INVESTIGATION (2007)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
The interaction of G-CSF with its receptor
JE Layton et al.
FRONTIERS IN BIOSCIENCE (2006)
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo
Claudia M. Gutschalk et al.
CANCER RESEARCH (2006)
Prognostic factors in adult soft tissue sarcomas of the head and neck: A single-centre experience
Remco de Bree et al.
ORAL ONCOLOGY (2006)
Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma
Yiwei Chi et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice
T Yoshioka et al.
CARDIOVASCULAR RESEARCH (2006)
G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth
QS Zhu et al.
BLOOD (2006)
Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+cells in cancer animal models
T Okazaki et al.
INTERNATIONAL IMMUNOLOGY (2006)
Head and neck mucosal melanoma
WM Mendenhall et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils
Y Ohki et al.
FASEB JOURNAL (2005)
Matrix metalloproteinases and angiogenesis
JE Rundhaug
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: Role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt
HS Suh et al.
JOURNAL OF IMMUNOLOGY (2005)
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Macrophage responses to hypoxia - Implications for tumor progression and anti-cancer therapies
C Lewis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization
J LeCouter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hematopoietic cytokines as tumor markers
B Mroczko et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck - An analysis of two Eastern Cooperative Oncology Group randomized trials
A Argiris et al.
CANCER (2004)
CSF-1 regulation of the wandering macrophage: complexity in action
FJ Pixley et al.
TRENDS IN CELL BIOLOGY (2004)
Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells
E Obermueller et al.
CANCER RESEARCH (2004)
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
C Murdoch et al.
BLOOD (2004)
Primary malignant melanoma of the oral mucosa
AD Rapidis et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes
TD Eubank et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck
S Ninck et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
S Gillessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx
JM Ritchie et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck - The Dana Farber Cancer Institute experience
R Haddad et al.
CANCER (2003)
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses
HH Wu et al.
CANCER (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells
T Natori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: A double-blind prospective randomized phase III study
K Saarilahti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
AD Colevas et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis
GM Sprinzl et al.
EUROPEAN JOURNAL OF CANCER (2001)
Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells
C Sugimoto et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze
JR Kouvaris et al.
WOUND REPAIR AND REGENERATION (2001)
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
MR Posner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: Phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis
JT Murray et al.
INFLAMMATION RESEARCH (2000)
Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells
T Tomita et al.
CANCER LETTERS (2000)
The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor
AC Ward et al.
LEUKEMIA (2000)
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor
LE Spitler et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
